-
Extraordinary measures for clinical trials due to COVID-19
| 09 October 2020 |
UPDATED. We are aware that COVID-19 has consequences with regards to the conduct of clinical trials in Denmark. Multiple factors play a role such as trial participants in quarantine, limited access to public places (including hospitals) due to the risk of spreading infections etc.
-
A rolling review of one more potential COVID-19 vaccine has started
| 06 October 2020 |
A rolling review of one more potential COVID-19 vaccine has been started by the European Medicines Agency, EMA. This happens only five days after the EMA started the same process for AstraZeneca’s potential COVID-19 vaccine.
-
EMA: Transparency and scientific independence – the basis for authorising COVID-19 vaccines in the EU
| 06 October 2020 |
The European Medicines Agency, EMA, has stated in an announcement that its high standards for transparency and independence will be upheld when its experts assess and potentially authorise COVID-19 medicines and vaccines. “We need to hurry, but we must never rush things through”, said Director General of the Danish Medicines Agency, Thomas Senderovitz.
-
Danish Medicines Agency takes tougher action to ensure the publication of clinical trial results
| 06 October 2020 |
A fine or imprisonment of up to four months is the ultimate punishment if the results from clinical trials of medicines are not published. The Danish Medicines Agency will be taking a tougher line on investigators – the so-called sponsors of clinical trials of medicines – if they do not publish the results of the trials they carry out.
-
EMA starts rolling review of a potential COVID-19 vaccine
| 01 October 2020 |
The European Medicines Agency, EMA, has started a rolling review of trial data on a potential COVID-19 vaccine. The vaccine is from AstraZeneca with which the European Commission signed a purchase contract about a month ago on behalf of Denmark (among others).
![2017](https://laegemiddelstyrelsen.dk/Content/Images/seo-thumbnail.png)
All items (450)
-
Time
- 2024 (13)
- 2023 (23)
- 2022 (20)
- 2021 (44)
- 2020 (62)
- 2019 (20)
- 2018 (37)
- 2017 (54)
- 2016 (53)
- 2015 (11)
- 2014 (13)
- 2013 (11)
- 2012 (11)
- 2011 (13)
- 2010 (9)
- 2009 (14)
- 2008 (7)
- 2007 (3)
- 2006 (10)
- 2009 (14)
- 2014 (13)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2020 (62)
- 2021 (44)
- 2022 (20)
- 2023 (23)
- 2008 (7)
- 2011 (13)
- 2013 (11)
- 2014 (13)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2019 (20)
- 2020 (62)
- 2021 (44)
- 2022 (20)
- 2023 (23)
- 2008 (7)
- 2009 (14)
- 2011 (13)
- 2013 (11)
- 2014 (13)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2019 (20)
- 2020 (62)
- 2022 (20)
- 2023 (23)
- 2008 (7)
- 2009 (14)
- 2011 (13)
- 2014 (13)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2020 (62)
- 2021 (44)
- 2023 (23)
- 2009 (14)
- 2011 (13)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2019 (20)
- 2020 (62)
- 2021 (44)
- 2022 (20)
- 2024 (13)
- 2008 (7)
- 2011 (13)
- 2013 (11)
- 2014 (13)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2019 (20)
- 2020 (62)
- 2021 (44)
- 2022 (20)
- 2024 (13)
- 2009 (14)
- 2010 (9)
- 2011 (13)
- 2013 (11)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2020 (62)
- 2021 (44)
- 2022 (20)
- 2023 (23)
- 2024 (13)
- 2007 (3)
- 2009 (14)
- 2011 (13)
- 2013 (11)
- 2014 (13)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2019 (20)
- 2020 (62)
- 2021 (44)
- 2022 (20)
- 2023 (23)
- 2006 (10)
- 2009 (14)
- 2010 (9)
- 2013 (11)
- 2014 (13)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2019 (20)
- 2020 (62)
- 2021 (44)
- 2022 (20)
- 2024 (13)
- 2007 (3)
- 2010 (9)
- 2011 (13)
- 2012 (11)
- 2013 (11)
- 2014 (13)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2019 (20)
- 2020 (62)
- 2021 (44)
- 2022 (20)
- 2023 (23)
- 2024 (13)
- 2007 (3)
- 2008 (7)
- 2009 (14)
- 2010 (9)
- 2012 (11)
- 2014 (13)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2019 (20)
- 2020 (62)
- 2021 (44)
- 2022 (20)
- 2023 (23)
- 2024 (13)
- 2010 (9)
- 2011 (13)
- 2012 (11)
- 2015 (11)
- 2016 (53)
- 2017 (54)
- 2018 (37)
- 2019 (20)
- 2020 (62)
- 2021 (44)
- 2022 (20)
- 2023 (23)
- 2024 (13)